Brief: Matinas Biopharma Announces Positive In Vivo Efficacy Results Of Oral LNC Docetaxel Formulation In A Melanoma Model

Matinas BioPharma Holdings

07/11/2023 12:34

Nov 7 (Reuters) - Matinas BioPharma Holdings Inc
 MTNB.A :
    * MATINAS BIOPHARMA ANNOUNCES POSITIVE IN VIVO EFFICACY
RESULTS OF
ORAL LNC DOCETAXEL FORMULATION IN A MELANOMA MODEL
    * MATINAS BIOPHARMA HOLDINGS INC - NO SYSTEMIC TOXICITIES
WERE
NOTED

Source text for Eikon:  ID:nGNX1KkX5C 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;))